Skip to main content

Myeloproliferative Disorders News

FDA Approves Imkeldi (imatinib) Oral Solution for the Treatment of Certain Forms of Leukemia and Other Cancers

CAMBRIDGE, Mass.-- November 25, 2024 --Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, announced today that the FDA has approved Imkeldi (imatinib) oral solution, the fir...

FDA Approves Jakafi to Treat Myelofibrosis

November 16, 2011 – The U.S. Food and Drug Administration today approved Jakafi (ruxolitinib), the first drug approved to specifically treat patients with the bone marrow disease myelofibrosis. ...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Multiple Myeloma, Blood Disorders